Because buy & hold is sometimes a bit too boring.

Take profits and reallocate a little. Less individual shares, more ETFs.

$TMDX (-0,07%) - Company presentation part 2

Why $TMDX (-0,07%) could be an opportunity - reasons and concerns

Positive:

• $TMDX (-0,07%) Is a demand-driven business. Selling products that people need usually means that the products sell themselves. In any economic climate, there are people waiting for organs.

• The business model of $TMDX (-0,07%) is very robust. When an organization buys an organ, it keeps the console. When it uses the organ, it immediately buys a new organ to replenish the console. If an organization wants to use the NOP service for transport only, the contracts usually provide for OCS to be used in some way, whether to house/monitor the organ during transport or to purchase OCS outright to house the organ once the organization receives it.

• The entire transplant industry is massively underutilized

• Why $TMDX (-0,07%) wins in transplants:

$TMDX (-0,07%) Could easily become a monopoly (especially NOP) or expand their lead. You start in a niche, dominate it and keep expanding.

• $TMDX (-0,07%) the NOP logistics command center:

• Unique competitive advantage:

Concerns:

• $TMDX Has only recently become profitable and is inconsistent. You only reached profitability a year ago.

Net income:

Q4 2023: 4 million $

Q1 2024: 12.2 million $

Q2 2024: 12.2 million dollars

Q3 2024: 4.2 million USD

• In the last four quarters, costs have risen faster than revenue. This is something you don't want to see in a company that has recently become profitable.

• $TMDX (-0,07%) Has about $330m in cash, but still has about $178m in net debt

• $TMDX (-0,07%) would be a candidate for loss absorption. The share price has fallen sharply for half a year. For people who are still holding the share with a book loss, a sale now would be a good opportunity to offset this with profits from this year.

• The sentiment at $TMDX is at a multi-year low. Having just posted their first QoQ decline (although still up 64% y/y), the aesthetics of their rising sales, which has led to a 900% return on share price in 4.5 years, is ruined. If $TMDX (-0,07%) delivers another disappointing quarter, it could leave a nasty taste in Wall Street's mouth in the long run, regardless of how well the business might be doing - much like $PYPL (+0,01%) and $SOFI (-0,02%)

• $TMDX has a very asset-heavy business model. They own a fleet of aircraft, they own hubs that store OCS consoles and maintain aircraft, they own vehicles for ground transportation. All these assets are not cheap to maintain. This is a very complex logistics network that needs to be utilized/utilized, as opposed to e.g. $SHOP (-0,3%) , $PLTR (-1,58%) and Co, whose entire business is based on software.

• The whole business depends on the generosity of others. Without donors, there is no business. It is not the case that $TMDX (-0,07%) can ramp up/scale organ production to higher numbers. I could see NOP and renting out this fleet in the future, for medical purposes only, could be a great way to expand the monopoly on transplants.

• has a very niche business. There are only a limited number of people looking for a new organ. This will lead to some restrictions on business growth unless they expand at some point.

Bottom line:

I think $TMDX (-0,07%) could be a good buy now. The current weakness in the numbers is fundamentally not due to weakness in the business, but it is being sold off heavily as if it is. Down 50% because the transplant industry as a whole is down ? Because more was spent this quarter on expanding the business for 2025 ? Because the QoQ increase could not be sustained due to aircraft maintenance ?

I will consider getting in, what stops me at the moment is that you can't control the supply, but if you continue to develop the technology and others also use your services, the growth should be able to be sustained.

Why $SHOP (-0,3%) is now a strong portfolio addition

In a rapidly changing digital economy $SHOP (-0,3%) has established itself as one of the leading providers of e-commerce solutions. Despite previous share price fluctuations, there is much to suggest that now could be the ideal time to add $SHOP (-0,3%) -shares into your portfolio. Here are the most important reasons:

---

1. booming e-commerce market

The global e-commerce market continues to grow rapidly. More and more companies and retailers are moving their business online. $SHOP (-0,3%) With its platform, the eCommerce platform offers the ideal solution for companies of all sizes to sell online.

According to forecasts, global e-commerce sales are set to grow at double-digit rates every year until 2027. $SHOP (-0,3%) is excellently positioned as a leading infrastructure provider to benefit massively from this trend.

---

2. market leader with a comprehensive ecosystem

$SHOP (-0,3%) has long been more than just a platform for online stores. With tools such as Shopify Payments, $SHOP (-0,3%) Capital and the logistics network $SHOP (-0,3%) Fulfillment Network, the company offers a complete ecosystem for retailers.

This vertical integration gives $SHOP (-0,3%) a decisive competitive advantage, as it can offer its merchants an all-round package from a single source - which strengthens customer loyalty and recurring sales.

---

3. expansion in the B2B and corporate sector

$SHOP (-0,3%) was long known as a platform for small and medium-sized companies. With Shopify Plus, however, the company is successfully penetrating the market for large companies. Major brands such as Heinz, Gymshark and Allbirds are already using the Shopify platform.

Increasing adoption in the enterprise sector could be a significant growth driver as larger companies with higher turnover provide greater scalability and stability.

---

4. innovation through AI and automation

$SHOP (-0,3%) is increasingly integrating artificial intelligence (AI) and automation solutions to provide retailers with personalized sales strategies and marketing campaigns. Features such as automated inventory management, AI-supported product recommendations and marketing automation improve retailers' efficiency and increase their sales potential.

---

5. strong fundamentals and growth plans

$SHOP (-0,3%) shows continuous sales growth and has recently improved its profitability. With a solid business model and long-term expansion plans, particularly in logistics and cross-border trade, the share price should have further upside potential.

---

6. attractive valuation after price correction

Following the turbulence in the technology sector and a temporary correction of the $SHOP (-0,3%) -share, the current valuation appears much more attractive. Long-term investors now have a favorable opportunity to invest in a leading growth stock.

---

Conclusion: Time for $SHOP (-0,3%) in the portfolio?

$SHOP (-0,3%) is one of the most promising companies in the global e-commerce sector. Its strong market position, comprehensive product range and clear expansion plans make the share an interesting addition to the portfolio - especially for long-term investors who are betting on the further digitalization and growth of online retail.

After being a mostly silent reader for over a year now, watching with interest what strategies and views others are pursuing:

Today I would like to share my first milestone with you - and most likely (never say never) my last.

After the last few weeks have been rather sideways, today I'm green again and have made a significant jump.

🎉A portfolio value of €1,000,000🎉

Briefly in advance:

My start in the world of finance began with a securities account that I inherited at the age of 20 due to sad circumstances. I never really got to grips with investments and 2-3 years later, I had completely different worries and suffering and would have gladly swapped the portfolio for a loved one again.

Now a little about my "strategy"

I inherited a lot of "blue chip" stocks and gradually sold some of them and opted for other stocks.

In my opinion, the "price increase" team is clearly superior to the "dividend" team at Getquin. I have always tried to find a healthy mix, and I have to admit that dividend stocks help me to get more involved with investing.

In the ~7 years I have been active so far, I have also had to learn the hard way and gain experience. Here are a few brief insights for those who are interested:

$TTE (+0,05%) and $AI (+0,1%) were my first self-made purchases, whereby I gradually $AI (+0,1%) I gradually increased my holdings and fortunately was able to take a stock split with me.

My first speculative share $NEL (+0,9%) had a price gain of 300% in the meantime, but was sold at a loss after disappointing figures.

During a professional training program during Corona, I bought shares $GME (+0,38%) I bought shares and took part in the rollercoaster ride in which I was able to realize a profit of €1,500 from a €6,000 investment and a lot of sweating and excitement.

I bought 0.05 $BTC (-1,64%) and was able to successfully hold it for 2 years and go from 0 to 0 before the BTC price went through the roof. You have to manage that first.

After the scandal of $WDI I thought, well the figures may be falsified but the company will have a conscience value and I burned another €1,500 at a share price of €1.22.

In addition, I couldn't quite believe the sanctions against Russia and shortly before the announcement of the sanctions $GAZP I bought shares worth €1,600.

At the end of the millions, the purchase of $PLTR (-1,58%) where I can currently record a 450% price gain.

( Thank you Jan Böhmermann, your video about this "evil" company was the best advertisement )

I am now happy with my portfolio. In the long term, I am still waiting $WCH (-0,06%) for a reasonably positive exit.

Of $SAP (+0,18%) as I also work with it at work and don't see any competition in the medium term as far as customized solutions are concerned.

I would also like to increase the position of $ENR (-1,26%) and generally increase my weighting with the Worlds funds.

I have currently set up savings plans of around €900 (€700 Worlds, €150 S&P 500, €50 EM)

In addition, I have a securities account not tracked here where I have been participating in a share program for employees for 10 years with my annual bonus payment from my employer. I also regularly watch videos of "Finanzbär" on Youtube where I am occasionally tempted to make individual purchases (e.g. $HIMS (-1,01%) and $SHOP (-0,3%) )

I can highly recommend it!

Fortunately, I can expect 3 salary increases in the next 12 months due to collective agreements and a change of position in the company.

I would like to use this to top up my savings plans and am considering investing €100 a month in $BTC (-1,64%) or $MSTR (-2,66%)

and we'll see.

My next goal?

Continue in the same way but don't forget that you are alive NOW and treat yourself to something. And if things go well, enjoy life in a southern country in my early 40s and no longer have to work 😁

With this in mind :

Cheers 🥂 thanks to all of you

Analyst updates, 19.11.

⬆️⬆️⬆️

- JEFFERIES raises the price target for NETFLIX from USD 800 to USD 1000. Buy. $NFLX (-0,04%)

- DEUTSCHE BANK RESEARCH raises the price target for SIEMENS from EUR 200 to EUR 210. Buy. $SIE (-0,04%)

- DZ BANK raises the price target for WALT DISNEY from USD 115 to USD 130. Buy. $DIS (+0,05%)

- KEPLER CHEUVREUX raises the target price for ALZCHEM from EUR 69 to EUR 73. Buy. $ACT (+0,97%)

⬇️⬇️⬇️

- BOFA downgrades SIEMENS from Buy to Neutral and raises target price from EUR 196 to EUR 200. $SIE (-0,04%)

- BERENBERG lowers the price target for BAYER from EUR 28 to EUR 22. Hold. $BAYN (+0,15%)

- BERENBERG lowers the price target for SMA SOLAR from EUR 21 to EUR 14. Hold. $S92 (-0,41%)

- DZ BANK downgrades SHOPIFY from Hold to Sell and raises target price from USD 68 to USD 91. $SHOP (-0,3%)

- STIFEL lowers the price target for BECHTLE from EUR 50 to EUR 45. Buy. $BC8 (-0,16%)

- WARBURG RESEARCH lowers the price target for JUNGHEINRICH from EUR 49 to EUR 47. Buy. $JUN3 (-0,8%)

- HAUCK AUFHÄUSER IB lowers the target price for KNAUS TABBERT from EUR 16 to EUR 8. Sell. $KTA (+0,37%)

- DEUTSCHE BANK RESEARCH lowers the price target for JOST WERKE from EUR 70 to EUR 60. Buy. $JST (-0,05%)

- GOLDMAN lowers the price target for TEAMVIEWER from EUR 18 to EUR 17. Buy. $TMV (+7,28%)